Skip to main content
. 2017 May 6;7(2):143–150. doi: 10.1093/jpids/pix026

Figure 2.

Figure 2.

Percentage of children with borderline or elevated lipids in a cohort of 553 human immunodeficiency virus (HIV)-infected and 300 HIV-uninfected children aged 4–9 at 2 study sites in Johannesburg, South Africa, stratified by HIV status and combination antiretroviral therapy regimen. *This figure uses the guidelines from the Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents [44]. Under guidelines from the National Cholesterol Education Program Expert Panel on Cholesterol Levels in Children [42, 43], 26.3% of the rotanivir-boosted lopinavir (LPV/r) group, 14.0% of the efavirenz (EFV) group, and 8.0% of the HIV-uninfected group had abnormal triglycerides. HDL, high-density lipoprotein; HIV−, HIV-uninfected; LDL, low-density lipoprotein; TC, total cholesterol.